develop companion diagnostics. Thermo Fisher Scientific on September 25 announced a partnership with GlaxoSmithKline and Pfizer to develop an NGS oncology test for solid tumors. The test will be used as a companion diagnostic for several drug programs after premarket approval from the FDA and other regulatory agencies. The test will apply to CNVs, gene […]
Major US equity markets fell in September due to continued geopolitical concerns in the Middle East and Ukraine as well as waning economic growth in China and weak manufacturing data in Europe. In addition, a divergence in monetary policy by major central banks has obscured global economic growth outlooks, as Europe and China are looking […]
According to a June 2014 Strategic Directions International analysis, the market for handheld devices is the fastest-growing segment among XRF instruments. The data in the report come from a survey of 127 XRF users worldwide. The information in this article was taken from the report, “X-Ray Fluorescence: New Frontiers for a Mature Technology,” which provides […]
Merck KGaA became the latest company to enlarge its stake in the laboratory-products market with its announcement on September 22 of an agreement to purchase Sigma-Aldrich for approximately €13.1 billion ($17 billion = €0.77 = $1) in cash (see page 2). Together, the firms will create a €4.7 billion ($6.1 billion) supplier of laboratory and […]
PerkinElmer has launched the AlphaPlex reagent technology for multiplex immunoassay analysis. AlphaPlex is based on the company’s Alpha (amplified luminescence proximity homogenous assays) technology, a homogeneous, bead-based, no-wash assay platform. Alpha Technology offerings also include the AlphaLISA and AlphaScreen reagents. Based on the transfer of energy between Donor and Acceptor beads, AlphaPlex can generate multiple […]
The UK government made public this month a third-party final report reviewing the country’s food-supply networks and their response to food adulteration in light of the 2013 EU horse-meat incident, when beef products were found to contain horse meat and other products from animals besides cow (see IBO 2/15/13). The government also published a response […]
Second quarter IBO Life Science Index sales grew 5.1%, 6.0% excluding currency, to $3,568 million. Operating profit jumped 11.2% to $780 million. Illumina’s strong financial performance accounted for roughly half of the Index’s organic sales and operating profit growth. Based on continuing operations, operating margin advanced 100 basis points to 19.6% of sales. Sequenom was […]
This fall’s edition of IBO’s biannual article highlighting selected new laboratory construction and openings focuses on academic and industrial investments. The table on page 4 lists new projects in the automobile industry and at medical schools. New labs in China, the UK, Europe and the US are also highlighted. China Several companies have recently announced […]
An unfortunate consequence of the recent explosion in next-generation sequencing (NGS) activity is the huge amount of generated data that are unused or not used to their full potential. Analysis of sequence data can take orders of magnitude more time than producing it and, as a result, is unable to keep pace. The existence of […]
The US economy showed further gains in August as second quarter GDP growth was revised from 4.0% to 4.2%, led by consumer spending and inventory surges. However, while growth was stronger than expected following a slow start to the year due to extreme weather conditions, housing prices showed signs of slowing, and labor markets were […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
